130 related articles for article (PubMed ID: 9316622)
1. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.
Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K; Terada K; Sugiyama T
Cancer Invest; 1997; 15(5):411-5. PubMed ID: 9316622
[TBL] [Abstract][Full Text] [Related]
2. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas.
Ikeda Y; Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
Ann Thorac Surg; 1996 Sep; 62(3):835-8. PubMed ID: 8784015
[TBL] [Abstract][Full Text] [Related]
3. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
[TBL] [Abstract][Full Text] [Related]
4. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
5. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O
Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190
[TBL] [Abstract][Full Text] [Related]
6. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
7. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors.
Shiga C; Shiga K; Hirayama K; Katayama M; Nishihira T; Mori S
Anticancer Res; 1994; 14(2B):651-6. PubMed ID: 8010723
[TBL] [Abstract][Full Text] [Related]
9. A paradigm for oncogene complementation in human breast cancer.
Roux-Dosseto M; Martin PM
Res Virol; 1989; 140(6):571-91. PubMed ID: 2694252
[TBL] [Abstract][Full Text] [Related]
10. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Ottestad L; Andersen TI; Nesland JM; Skrede M; Tveit KM; Nustad K; Børresen AL
Acta Oncol; 1993; 32(3):289-94. PubMed ID: 8100712
[TBL] [Abstract][Full Text] [Related]
11. DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.
Medl M; Sevelda P; Czerwenka K; Dobianer K; Hanak H; Hruza C; Klein M; Leodolter S; Müllauer-Ertl S; Rosen A
Gynecol Oncol; 1995 Dec; 59(3):321-6. PubMed ID: 8522248
[TBL] [Abstract][Full Text] [Related]
12. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral heterogeneity of hst-1 gene amplification in esophageal carcinoma with reference to DNA stem line heterogeneity.
Chikuba K; Saito T; Uchino S; Inomata M; Kobayashi M
Jpn J Clin Oncol; 1995 Dec; 25(6):229-33. PubMed ID: 8523818
[TBL] [Abstract][Full Text] [Related]
14. [int-2 and c-erbB-2 gene amplification in urological cancers].
Sato K; Kato T; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1957-63. PubMed ID: 1361954
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
16. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas.
al-Kasspooles M; Moore JH; Orringer MB; Beer DG
Int J Cancer; 1993 May; 54(2):213-9. PubMed ID: 8098013
[TBL] [Abstract][Full Text] [Related]
17. Gene amplifications in advanced-stage human prostate cancer.
Fournier G; Latil A; Amet Y; Abalain JH; Volant A; Mangin P; Floch HH; Lidereau R
Urol Res; 1995; 22(6):343-7. PubMed ID: 7740653
[TBL] [Abstract][Full Text] [Related]
18. Amplified genes in cancer in upper digestive tract.
Yoshida T; Sakamoto H; Terada M
Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412
[TBL] [Abstract][Full Text] [Related]
19. Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas.
Wagata T; Ishizaki K; Imamura M; Shimada Y; Ikenaga M; Tobe T
Cancer Res; 1991 Apr; 51(8):2113-7. PubMed ID: 1826231
[TBL] [Abstract][Full Text] [Related]
20. Multiple genetic lesions in laryngeal squamous cell carcinomas.
Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
